Approval · Notice of Compliance 13993 · 2013
VIRACEPT: Notice of Compliance 13993
Issued January 7, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13993
- Date
- January 7, 2013
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph; Warnings and Precautions, Drug Interactions, Overdosage and COnsumer Information
- Therapeutic class
- Hiv protease inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VIRACEPT | Not yet assigned | — |
Medicinal ingredients
- NELFINAVIR MESYLATE 292.25 MG per TAB
- NELFINAVIR MESYLATE 730.6 MG per TAB
- NELFINAVIR MESYLATE 58.5 MG per G